Hyper-Transmissible SARS-CoV-2 Variant Detected in United States Wastewater

▴ Hyper-Transmissible SARS-CoV-2 Variant Detected in United States Wastewater
GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of hyper-transmissible SARS-CoV-2 from the B.1.1.7 lineage in three wastewater treatment plants in the United States.

GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of hyper-transmissible SARS-CoV-2 from the B.1.1.7 lineage in three wastewater treatment plants in the United States. This is an additional piece of evidence that the UK variant or a UK variant-like strain is spreading in the United States. GT Molecular detected the strain using its highly sensitive digital PCR test for the SARS-CoV-2 virus. This test is available immediately both as a fee-for-service and as a complete, ready-to-use PCR kit for testing labs.

"Molecular biologists from around the world have come together to advance wastewater-based epidemiological approaches over the last year. This is an excellent demonstration of the power of these approaches, wherein an entire community can be tested for the presence of a variant in a single sample in a matter of hours," says, Dr. Rose Nash, Director of R&D at GT Molecular.

GT Molecular will continue to screen communities around the country for the presence of this variant in their community wastewater through their nationwide wastewater testing program. Additionally, GT Molecular will provide the molecular reagents they designed and optimized for this analysis to the greater wastewater-based epidemiology community.

"Our team continues to respond rapidly to this pandemic by releasing both a fee-for-service test for communities and an all-in-one PCR kit for testing labs for this dangerous variant," says GT Molecular CEO Christopher McKee. "Our new analysis will allow communities and testing labs to quickly determine whether the SARS-CoV-2 B.1.1.7 variant is present while giving health officials timely data to make decisions that can better help manage outbreaks."

About GT Molecular

Whether for cancer, GMO, or harmful pathogens, GT Molecular (GTM) is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests for researchers and the Molecular Diagnostics community. GTM's molecular app technology is an easy-to-use, end-to-end solution for rapid deployment and provides reliable and consistent measurements while detecting as little as 1-3 molecules of target nucleic acid.

Tags : #GTMolecular #UnitedStates #CovidInfection #Hyper-TransmissibleSARS-CoV-2Variant #wastewaterTreatmentplants #SARS-CoV-2virus #PCRKITS #Covid-19

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026